Background-One-year restenosis rate after balloon angioplasty of long lesions in below-the-
Introduction
Critical limb ischemia (CLI), characterized by ischemic rest pain and/or tissue loss, represents the most advanced state of peripheral artery disease, burdened by high morbidity and mortality 1, 2 . CLI generally occurs in diabetics with extensive atherosclerotic disease of belowthe-knee (BTK) vessels 1 .
The optimal strategy for treating CLI patients, however, has not been clearly defined yet:
the outcome of medical therapy is unsatisfactory 3 , and early, aggressive percutaneous revascularization with the aim to obtain direct flow to the foot is increasingly considered as firstline strategy 4, 5 . Indeed, although vessel patency alone cannot match patient-centered clinical endpoints 6 , and any endovascular program has to be integrated in a network-based system of care involving different professional figures 7, 8 , an increased cutaneous oxygen pressure due to successful revascularization promotes infection clearance and ulcer granulation at a crucial timepoint 9 .
The efficacy of conventional percutaneous transluminal angioplasty (PTA) using conventional balloons, however, is limited by the high 12-month restenosis and target lesion revascularization (TLR) rates 10 . Loss of vessel patency affects the healing process resulting in no healing, decrease-increase behavior of the lesion or appearance of new foot lesions 11 . While drug-eluting stents (DES) may offer a therapeutic alternative to PTA in the BTK district 12, 13 , widespread use in CLI patients is limited by the complex pattern of BTK atherosclerosis, characterized by long, calcific stenoses/occlusions.
Local delivery of paclitaxel via drug eluting balloons (DEB) has recently shown
promising results in the treatment of femoropopliteal disease 14 , and, in the BTK district, a reduction of 3-month binary restenosis has been observed in comparison with historical controls endpoints 6 , and any endovascular program has to be integrated in a network-base se ed d sy s s s st stem m em o o of f f ca c re nvolving different professional figures 7, 8 , an increased cutaneous oxygen pressure due to u ucc cc ces es ssf sf sful ul ul r r rev ev vas scu cu cula larization promotes infection c c cle lea arance and ulc cer e e gr gran an anu ul u ation at a crucial timepoin n nt t 9 .
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We designed a prospective, randomized trial designed to compare the performance of a novel DEB (Amphirion In.Pact, Medtronic, Santa Rosa, CA) with conventional PTA in diabetics with de-novo, long atherosclerotic lesions of the BTK district, using 1-year binary restenosis rate as primary endpoint.
Methods

Study design
The The study was performed without any industry financial support.
Study Patients
From November 2010 through October 2011, all consecutive diabetic patients with CLI undergoing angioplasty of at least one BTK vessel at our center were screened for enrollment.
Study design
The Drug Eluting Balloon in peripherAl inTErvention for Below The Knee angioplasty ev val al alua ua uati ti tion on n ( ( (DE D D BA BA BATE T -BTK) is a single-center, pa pa para a allel-group, pr ros os o pe ect ct ctiv iv ive, e randomized, opena abe e el l involvin ng g th th t e e e bl bl lin in i de de ded d d ev ev eva al alua ua ati ti t o on on of f end d d p p poin n nts s s (PR PR PROB OB BE E) E) t tr ri ia al l 17 17 17 e ev va valu luat at atin in ing g th th he ef ef effi fi f ca ca acy cy o of f f a 0. .01 01 014" 4" 4" g g gui uide de dewi wire re e-c c com om mpa pa ati tibl ble e e DE DE DEB B B ( (A (Amp mp mphi hi hir r rion on on In In n.P P Pac c ct, t, M M Me ed edtr tr tron on nic c c) ) ) vs vs vs. . s st stan an nda da dard rd r P P PT TA TA Amphirion D D Dee ee eep, p, p, M M Med ed e tr t t on on nic ic c) ) in in n r r re edu du d ci ci cing ng ng 1 1 12-2-2 mo mo mont nt nth h h re rest st sten en enos os o is is is r r rat a e e e in in n d d dia ia iabe be beti t c c c pa pa pati ti tien en ents t with CLI I I Inclusion criteria were: presence of diabetes, CLI (Rutherford class 4), stenosis or occlusion 40mm of at least one tibial vessel with distal run off to the foot, and agreement to 12-month angiographic evaluation. Exclusion criteria were: life expectancy < 1 year, allergy to paclitaxel, contraindication to combined antiplatelet treatment and planned major amputation before angiography.
Lesions were randomly assigned to one of the two study arms after successful passage of the guidewire. Randomization was performed in blocks of ten with the use of computergenerated random digits, and the assignments were placed in sealed envelopes.
Study Procedures
Interventions were performed mainly by antegrade approach and with the use of 6-French sheaths. In case of failure to recanalize, a retrograde approach was attempted. In DEB group, pre-dilatation of the target lesion with standard balloon(s) was always performed before dilatation with DEB. The DEB used in this study has been previously described 15 . The DEB/vessel diameter ratio was planned to be 1:1. DEB available during the study period had a diameter of 2.5 to 4.0 mm and a length of 40 to 120 mm. Radiopaque rulers were used to ensure that the zone treated with DEB consistently exceeded of at least 10mm at the proximal and distal edges the area predilated with standard balloons, in order to avoid geographic miss. If more than 1 balloon was used per lesion, the overlap zone was at least 5 mm. Inflation time was at least 2 minutes for both DEB and PTA arms. In case of flow-limiting dissection or residual stenosis of more than 30%, a prolonged dilation of up to 3 min was performed. Drug eluting coronary stents (Xience V, Abbott, CA, USA) were used as a bailout. Technical success was defined as restoration of direct flow in the target vessel with run-off to the foot and a residual stenosis of less than 30%. Clinical success was defined as technical success without clinical events during nterventions were performed mainly by antegrade approach and with the use of f 6 6 6-F -F Fre enc nc nch h h heaths. In case of failure to recanalize, a retrograde approach was attempted. In DEB group, pr re-e-di di dila la lat ta tati ti tion on on of f th th the e target lesion with standard ba ba ball lo oon(s) was alw w ways s pe pe perf r ormed before hospitalization. Inflow lesions located in the femoropopliteal segment were treated by standard techniques during the same session. In patients with bilateral CLI, an additional procedure for the revascularization of the contralateral limb was planned in a different session to limit the risk of x-rays exposition and contrast-induced nephropathy, maintaining the same randomization arm.
All patients were taking aspirin 100 mg daily. After sheath insertion, 70 IU/Kg heparin was administered. Post-intervention dual antiplatelet therapy with aspirin 100 mg and clopidogrel 75 mg once daily was given at least for 4 weeks and 100 mg aspirin was given daily thereafter.
Follow-up
Once discharged, patients were followed in a multidisciplinary, dedicated foot clinic to facilitate healing process and recovery of the ambulatory function 7 . Office visits were scheduled 2 days/week for the first 2 months, once a week for the third month and then every two weeks.
Minor amputations which were planned before the interventions were performed 2-4 weeks after revascularization and included: finger amputations, metatarsal amputation due to necrosis/infection of tissues and bones with preservation of healthy surrounding tissue. All patients were scheduled to be re-admitted for control peripheral angiography at 12 months.
Before angiography, duplex ultrasound (DUS) of the target vessel was consistently performed. In case of clinical CLI recurrence, angiography and repeat revascularization were performed within one week from diagnosis. In patients undergoing clinically-driven repeat angiography of the target limb between 9 months and 12 months and who did not show evidence of restenosis of the target lesion, scheduled angiography at 12 months was not performed if DUS evaluation was clearly diagnostic for vessel patency with no restenosis.
Study Endpoints and Definitions
Once discharged, patients were followed in a multidisciplinary, dedicated foot c cli li ini nic c c to to o f f fac ac acil il ilit i ita ate healing process and recovery of the ambulatory function 7 . Office visits were scheduled 2 da ays ys ys/w /w /wee eek k k fo fo for r th h he e e fi first 2 months, once a week fo o or r r th h he third month h an a d d th th the e en every two weeks.
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The primary endpoint of the study was the comparison of 12-month binary restenosis rates between the DEB and PTA groups. Restenosis was defined by angiography as a reduction in the luminal diameter >50% according to the worst angiographic view within the treated lesion plus the 10-mm segments proximal and distal to it or, in the few patients who did not undergo 12-month angiography, as a peak systolic velocity ratio (PSVR) 2.5 by DUS.
Pre-specified secondary endpoints of the study were: 1. Clinically-driven target lesion revascularization (TLR), defined as repeat percutaneous intervention or surgical by-pass graft due to the angiographic evidence of restenosis at level of the treated lesion ±10 mm, in presence of at least one of the following criteria: a) recurrence of pain in the foot at rest which increased in the supine position; b) recurrence of foot lesion or evidence during follow-up of foot lesion size decrease-increase behavior; c) appearance of new foot lesion. 2. Major amputation, defined as unplanned amputation of the target limb where prosthesis was required for standing or walking.
Target vessel occlusion (either by angiography or DUS).
Acquired angiograms and DUS scans were reviewed by two blinded investigators who did not actively participate in recruitment (I.P. and G.V.) and who had no knowledge of clinical status and randomization group.
Post-hoc analyses was performed for the cumulative 12-month prevalence of major adverse events (MAE: death, major amputation, TLR, and Rutherford class 4) in the two groups, 12-month angiography, as a peak systolic velocity ratio (PSVR) 2.5 by DUS.
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Further post-hoc exploratory comparisons were performed between long (>100 mm) vs. shorter lesions, total occlusions vs. stenosis, and true lumen vs. subintimal recanalization technique.
Statistical Analysis
Values are reported as numbers with relative percentage or standard deviation. Nominal variables were compared by Fisher's exact test; continuous variables were compared with t-test.
Twelve-month binary restenosis rate, the primary endpoint of the study, was compared with
Fisher's exact test. Kaplan-Meier estimates and log-rank test survival methods were used to assess freedom from TLR, a secondary endpoint. Cohen's k statistics was used to compare angiography and DUS for detection of restenosis. All statistical computations were performed using SPSS version 17 (SPSS Inc., Chicago, IL).
Assuming a restenosis rate of 60% in the PTA group, as reported for patients with extensive infrapopliteal disease 10 , we hypothesized that DEB would halve the restenosis rate to 30% on the basis of the extremely positive result reported for DEB in the superficial femoral artery. 18, 19 A minimum of 63 evaluable lesions per group were considered necessary to have an 90% power (2-sided 5% significance level) to detect a 50% relative risk reduction (RRR) in the DEB group. The number of lesions per group was further increased to 70 in order to maximize study power.
Assuming a rate of eligible lesions/patient=1.3, a minimum of 110 patients had to be enrolled in the study. The number of patients was increased to 130 considering a drop-out rate of 20% due to the expected high morbidity and mortality in CLI patients.
assess freedom from TLR, a secondary endpoint. Cohen's k statistics was used to to o c com om ompa pa pare re re angiography and DUS for detection of restenosis. All statistical computations were performed us sin in ng g g SP SP SPSS SS SS v v versi si ion on on 17 (SPSS Inc., Chicago, IL) ) ). .
Assumi min ng g a a r re es ste e eno no nosi si is s ra rate te e o o of f 6 6 60 0% % in n n t t the PT PT PTA gr gr grou oup, p, a as s re e f po port rted ed ed f for or r p p pat atie ie ent nt nts s s wi w w th th h ex xte te tens ns nsiv iv i e e in in nfr fr frap apop op opli lite tea al d dis isea a ase se 10 10 , we w we h h hyp yp ypot ot oth he hesi si size ze ed d th that at a D D DEB EB EB w w wo ou ould ld ld ha ha alv v ve e th th he e re re r st st ten en enos s sis r rat ate e e to to o 30% on the b bas as a is is i o o of f f th th he e ex extr tr trem em emel el ely y y po po posi i iti ti tive ve ve r r res es esul ul u t t t re re epo po port ted ed ed f f for or or D D DEB EB EB i i in n n th th he e e su su supe pe erf rf fic ic icia ia al l l fe f moral 
Results
Patients and Lesions
During the study period, 156 patients were screened for study enrolment and 132 met the inclusion criteria and were randomized, 65 patients (80 lesions in 71 limbs) to DEB and 67 (78 lesions in 72 limbs) to PTA (Figure 1) . Baseline clinical characteristics were similar between study groups ( Table 1) . Ten per cent of the patients in each study arm were on chronic dialysis and the majority of patients had 0-1 patent tibial arteries at baseline.
Procedural and angiographic characteristics are reported in Table 2 . The most frequently treated vessel was the anterior tibial artery (ATA). Treated lesions had a high degree of complexity in both study arms, as 80% of the lesions were total occlusions and more than 20%
were heavily calcified. Subintimal recanalization was performed in one fifth of the lesions.
About 50% of patients in both study arms underwent inflow lesion treatment. Technical and clinical success was obtained in all patients.
Follow-up and clinical outcome
No major adverse event occurred in-hospital. Eight patients died during follow-up: causes of death included sudden death (n=3), respiratory failure (n=1), stroke (n=1), heart failure (n=1), and sepsis (n=1). Percentages of cardiac vs. noncardiac death in the two groups were not significantly different.
Of the 124 patients alive at 12 months (60 patients with 74 lesions in DEB group vs. 64 patients with 74 lesions in PTA group), angiographic follow-up could not be obtained in 13 patients (5 patients for worsening of pre-existing renal failure, 2 for major stroke, 2 for congestive heart failure and 4 patients refused the examination), who underwent DUS. In the 135 lesions with both angiographic and DUS follow-up assessment, agreement for restenosis complexity in both study arms, as 80% of the lesions were total occlusions and m m mor r re e th th than n an 2 2 20% 0 0%
Ab Abou ou out t t 50 50 50% % % of of o p pat at ati ie ient n s in both study arms under r rw w we en nt inflow lesio on n n trea ea atm tm tment. Clinical and angiographic data of 12-month follow-up are presented in Table 3 The advantage conferred by DEB on restenosis resulted in a significant decrease in clinically-driven TLR, a secondary endpoint of the study. TLR has an important prognostic value in CLI patients, as early failure of endovascular recanalization was found to predict limb loss and poor prognosis 20 , and repeat interventions with multiple contrast exposures are harmful in these very sick patients with frequent life-threatening comorbidities. Besides major amputation, our study did not have pre-planned endpoints of minor amputation and healing due to the fact that vessel patency alone is considered necessary but not sufficient to guarantee amputation-free survival. clinically-dri ive ve ven n n TL TL TLR, R, R, a a a sec ec econ on o da da dary ry r e e end nd dpo po poin in int t t of of of t the he he s s stu tu t dy dy dy. . TL TL TLR R R ha ha h s s an an an i i imp mp mpor or o ta ta ant nt nt p p pro ro rogn gn g ostic valu ue e more favorable distribution of Rutherford classes at follow-up and faster index ulcer healing in the DEB group.
Treatment with DEB, however, did not translate to a significantly higher rate of limb salvage due to the very low rate of major amputations (1 limb out of 143). This low rate of limb loss may depend on several factors: 1) patients were enrolled in the study only after successful wiring of the target vessel and, therefore, the rate of major amputation observed cannot be compared to that derived from studies designed on an intention-to-treat basis; 2) we established a dedicated multidisciplinary team providing wound care and continuous surveillance regimen of the foot lesion and vessel patency, including fast-track angiography and re-intervention when clinically needed 8, 21 . We previously showed the long-term benefit of this integrated multidisciplinary framework in this high-risk subset of patients 7 .
The safety of DEB, moreover, was similar to conventional balloons, as no acute thrombosis occurred on 1 month dual antiplatelet therapy in both arms. In few cases, DEB were associated with a limited increase in reference vessel diameter at follow-up. Longer follow-up will clarify if this phenomenon is of clinical relevance.
Study Limitations
Like many device trials in interventional cardiology, this is not a blinded study. In addition, patients were enrolled only in a single, high-volume center that might have a unique patient referral pattern and interventional technique. In addition, this study had no financial support and no external angiography or DUS core laboratory was available for adjudication of the endpoints.
However, the size of the observed effect and the additional evidence in favor of DEB in the femoropopliteal district 14 leaves few chances for these results to be controverted in a multicenter randomized study. We used everolimus drug-eluting stents as a bailout, which could have clinically needed 8, 21 . We previously showed the long-term benefit of this integra at te ted d d multidisciplinary framework in this high-risk subset of patients 7 .
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